Cargando…

Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups

We describe the results of two vaccinations of a self-experimenting healthy volunteer with SARS-CoV-2-derived peptides performed in March and April 2020, respectively. The first set of peptides contained eight peptides predicted to bind to the individual’s HLA molecules. The second set consisted of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rammensee, Hans-Georg, Gouttefangeas, Cécile, Heidu, Sonja, Klein, Reinhild, Preuß, Beate, Walz, Juliane Sarah, Nelde, Annika, Haen, Sebastian P., Reth, Michael, Yang, Jianying, Tabatabai, Ghazaleh, Bösmüller, Hans, Hoffmann, Helen, Schindler, Michael, Planz, Oliver, Wiesmüller, Karl-Heinz, Löffler, Markus W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146137/ https://www.ncbi.nlm.nih.gov/pubmed/33923363 http://dx.doi.org/10.3390/vaccines9050428

Ejemplares similares

The Peptide Vaccine of the Future
por: Nelde, Annika, et al.
Publicado: (2021)

HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation
por: Roerden, Malte, et al.
Publicado: (2020)

A Simple and Rapid Method for Quality Control of Major Histocompatibility Complex–Peptide Monomers by Flow Cytometry
por: Chandran, P. Anoop, et al.
Publicado: (2017)

Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics
por: Wacker, Marcel, et al.
Publicado: (2023)

Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial
por: Schuhmacher, Juliane, et al.
Publicado: (2020)

HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients
por: Tegeler, Christian M., et al.
Publicado: (2022)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
por: Roerden, Malte, et al.
Publicado: (2019)

Antigen Targets for the Development of Immunotherapies in Leukemia
por: Bauer, Jens, et al.
Publicado: (2019)

More Than Just Tumor Destruction: Immunomodulation by Thermal Ablation of Cancer
por: Haen, Sebastian P., et al.
Publicado: (2011)

Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome
por: Marconato, Maddalena, et al.
Publicado: (2022)

Long-Term Follow-Up of COVID-19 Convalescents—Immune Response Associated with Reinfection Rate and Symptoms
por: Seller, Anna, et al.
Publicado: (2023)

Simultaneous Identification of Functional Antigen-Specific CD8(+) and CD4(+) Cells after In Vitro Expansion Using Elongated Peptides
por: Schuhmacher, Juliane, et al.
Publicado: (2022)

Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens
por: Nelde, Annika, et al.
Publicado: (2022)

Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma
por: Bilich, Tatjana, et al.
Publicado: (2020)

Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome
por: Hackenbruch, Christopher, et al.
Publicado: (2023)

The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer
por: Gouttefangeas, Cécile, et al.
Publicado: (2023)

SARS‐CoV‐2‐reactive T‐cell receptors isolated from convalescent COVID‐19 patients confer potent T‐cell effector function
por: Brunk, Fabian, et al.
Publicado: (2021)

Biologie und Pathologie von Coronaviren
por: Traxler, Selina, et al.
Publicado: (2021)

Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire
por: Haen, Sebastian P., et al.
Publicado: (2020)

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals
por: Bilich, Tatjana, et al.
Publicado: (2021)

Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia
por: Nelde, Annika, et al.
Publicado: (2021)

Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort
por: Tegeler, Christian M., et al.
Publicado: (2022)

Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination
por: Maringer, Yacine, et al.
Publicado: (2022)

Activated integrins identify functional antigen-specific CD8(+) T cells within minutes after antigen stimulation
por: Dimitrov, Stoyan, et al.
Publicado: (2018)

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
por: Heitmann, Jonas S., et al.
Publicado: (2021)

Staining of activated ß(2)-integrins in combination with CD137 and CD154 for sensitive identification of functional antigen-specific CD4(+) and CD8(+) T cells
por: Schöllhorn, Anna, et al.
Publicado: (2023)

Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity
por: Nelde, Annika, et al.
Publicado: (2022)

A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
por: Rammensee, Hans-Georg, et al.
Publicado: (2019)

Integrin Activation Enables Sensitive Detection of Functional CD4(+) and CD8(+) T Cells: Application to Characterize SARS-CoV-2 Immunity
por: Schöllhorn, Anna, et al.
Publicado: (2021)

Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models
por: Lübke, Maren, et al.
Publicado: (2019)

Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer
por: Hoffmann, Elgin, et al.
Publicado: (2021)

The immunopeptidomic landscape of ovarian carcinomas
por: Schuster, Heiko, et al.
Publicado: (2017)

TOF(IMS) mass spectrometry-based immunopeptidomics refines tumor antigen identification
por: Hoenisch Gravel, Naomi, et al.
Publicado: (2023)

CAF-immune cell crosstalk and its impact in immunotherapy
por: Maia, Ana, et al.
Publicado: (2022)

Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo
por: Teck, Anja Tatjana, et al.
Publicado: (2021)

Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo
por: Teck, Anja Tatjana, et al.
Publicado: (2020)

Gα(s)-coupled receptor signaling and sleep regulate integrin activation of human antigen-specific T cells
por: Dimitrov, Stoyan, et al.
Publicado: (2019)

First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications
por: Löffler, Markus W., et al.
Publicado: (2018)

Individualisierte Immuntherapie von Tumorerkrankungen mittels Peptidimpfstoffen – Funktioniert das vielleicht doch?
por: Rammensee, Hans-Georg, et al.
Publicado: (2020)

CD4+ T Cells: Multitasking Cells in the Duty of Cancer Immunotherapy
por: Richardson, Jennifer R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8vbpu6ajdv6ef1hejfj5t8ghi8